A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
25 Apr 2017: Trial registered, NCT03128359
30 May 2017: Trial started, NCT03128359
The trials
NCT03128359: High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
State
Completed
Phase
Phase 2
People
38 taking part
Started
30 May 2017
Primary completion
1 Aug 2020
Arms
Regimen B (fludarabine, busulfan, PBSC HCT, GVHD prophylaxis)
Results
Posted on the registry
25 Apr 2017: Trial registered
30 May 2017: Trial started
15 Sep 2021: Trial completed
9 Jun 2023: Trial results posted
How the status changed
19 Nov 2026: First set: Phase 2 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.